When.com Web Search

  1. Ads

    related to: treatment for pulmonary fibrosis guideline

Search results

  1. Results From The WOW.Com Content Network
  2. Idiopathic pulmonary fibrosis - Wikipedia

    en.wikipedia.org/wiki/Idiopathic_pulmonary_fibrosis

    12 per 100,000 people per year [4] Idiopathic pulmonary fibrosis (IPF) synonymous with cryptogenic fibrosing alveolitis[5] is a rare, progressive illness of the respiratory system, characterized by the thickening and stiffening of lung tissue, associated with the formation of scar tissue.

  3. Pulmonary fibrosis - Wikipedia

    en.wikipedia.org/wiki/Pulmonary_fibrosis

    Pulmonary fibrosis. Pulmonary fibrosis is a condition in which the lungs become scarred over time. [1] Symptoms include shortness of breath, a dry cough, feeling tired, weight loss, and nail clubbing. [1] Complications may include pulmonary hypertension, respiratory failure, pneumothorax, and lung cancer. [2]

  4. Interstitial lung disease - Wikipedia

    en.wikipedia.org/wiki/Interstitial_lung_disease

    Interstitial lung disease. Interstitial lung disease (ILD), or diffuse parenchymal lung disease (DPLD), [3] is a group of respiratory diseases affecting the interstitium (the tissue) and space around the alveoli (air sacs) of the lungs. [4] It concerns alveolar epithelium, pulmonary capillary endothelium, basement membrane, and perivascular and ...

  5. Chronic obstructive pulmonary disease - Wikipedia

    en.wikipedia.org/wiki/Chronic_obstructive...

    Chronic obstructive pulmonary disease (COPD) is a type of progressive lung disease characterized by chronic respiratory symptoms and airflow limitation. [8] GOLD 2024 defined COPD as a heterogeneous lung condition characterized by chronic respiratory symptoms (dyspnea or shortness of breath, cough, sputum production and/or exacerbations) due to abnormalities of the airways (bronchitis ...

  6. Pirfenidone - Wikipedia

    en.wikipedia.org/wiki/Pirfenidone

    Medical uses. In the European Union, pirfenidone is indicated for the treatment of mild-to-moderate idiopathic pulmonary fibrosis. It was approved by the European Medicines Agency in 2011. [8][6] In October 2008, it was approved for use in Japan, in India in 2010, and in China in 2011 (commercial launch in 2014).

  7. Pulmonary rehabilitation - Wikipedia

    en.wikipedia.org/wiki/Pulmonary_rehabilitation

    Pulmonary rehabilitation. Pulmonary rehabilitation, also known as respiratory rehabilitation, is an important part of the management and health maintenance of people with chronic respiratory disease who remain symptomatic or continue to have decreased function despite standard medical treatment. It is a broad therapeutic concept.

  1. Ad

    related to: treatment for pulmonary fibrosis guideline